As we close out 2016, I’m not surprised to be reporting and commenting on new survey data by the Kaiser Family Foundation showing that 19 million Americans have purchased and imported lower cost medication from Canada and other countries. I suspect the number is higher and I’m sure it’s not high enough, as I’ll discuss at the conclusion of this post.
First, as reported in Kaiser Health News: “As drug prices have spiraled upward in the past decade, tens of millions of generally law-abiding Americans have committed an illegal act in response: They have bought prescriptions outside the U.S. and imported them.” The Kaiser story also reports that many such purchases are made online and while the FDA warns that many online pharmacies are not safe, “…many medicines purchased from another country are the same as the ones patients buy in the U.S.” That’s all true. The key to safety when buying medications internationally is only purchasing from properly verified websites, ones approved by PharmacyChecker.
Just to recap why importation is a lifeline, let’s look at some highlights from recent data. (more…)
Tagged with: AARP, Kaiser Family Foundation, price watch
People’s Pharmacy on NTI Drug Savings in Canada
This past summer we wrote about The Graedon’s Guide to Saving Money on Medicine, by the People’s Pharmacy, as a very worthwhile read. One of its sections talked about Narrow Therapeutic Index drugs for which generics are usually low cost and available in the U.S. but for some patients only the brand works: and the brands are very expensive. NTI drugs are those for which the precision of a medication’s dosage is of even greater importance than for most medications. Often these drugs are measured in micrograms not milligrams.
In its Guide, the People’s Pharmacy mentioned several popular medications that fall into the NTI category. We researched their prices and found medications on which Canadian online pharmacies offer spectacular savings, often 80%. They wrote about some of our findings in an article this week called: Can you trust Canadian online pharmacies?
As we’ve written before, many Canadian online pharmacies are really international online pharmacies because for years they’ve been partnering with pharmacies in other countries not just filling orders from Canada. But what was interesting about our data on the NTI drugs is that most of the lowest prices were in fact in Canada, not international pharmacies elsewhere.
Expect more in the New Year on how to get to the brand name drug you want at a price you can afford – including a deeper discussion on Narrow Therapeutic Index Drugs.
Tagged with: graedon, People's Pharmacy
For the record, while I supported Obama for president, I was highly critical of the Obama administration for its obscenely cozy relationship with the pharmaceutical industry, one that has led to unprecedented increases in drug prices during his tenure. During his first presidential campaign, President Obama had vowed to stand up to drug companies, and he supported allowing Americans to import medication to find savings in other countries. He ended up making a deal with Big Pharma to help him pass Obamacare, dumping his support for Medicare drug prices negotiations and importation.
Candidate Donald Trump voiced his support for federal drug price negotiations to bring down drug prices under Medicare and allowing consumers access to lower drug prices from overseas. Those are two policies that the pharmaceutical industry has spent hundreds of millions of dollars defeating over the past decade through large contributions to Democrats and Republican alike in Congress. Of course, Americans can order medications online from foreign countries and import them for personal use, but under the Obama administration it has become more difficult and remains technically illegal.
Mr. Trump states on his website: “Congress will need the courage to step away from the special interests and do what is right for America.” During the Republican Primary President-Elect Trump vowed to stand up to the drug companies, mocking the career politicians who take their money and do their bidding in Congress.
From the Right, Americans who hate the heavy hand of big government will laud a President Trump that tells the FDA not to interfere with their freedom to purchase a lower cost medication from Canada or another country. From the Left and in states that border Canada, such as Michigan, Americans would love to see a president who will stand up to the outrageous U.S. pricing policies of multinational pharmaceutical companies by taking actions to expand access lower cost imported medications.
With high drug prices viewed as the #1 healthcare cost concern in the county, ALL AMERICANS WANT TO SEE TRUMP STAND UP TO BIG PHARMA.
Now let’s see if he does.
Tagged with: trump
Earlier this month 33 members of Congress sent a letter to President Obama asking him to use executive authority to tackle the crisis of high drug prices in the U.S. The gist of the letter is that Congress is paralyzed (surprise surprise) to act. So, while we wait, and wait, and wait for Congress — the urgency of high drug prices calls for executive action.
One of the steps recommended is to expressly permit Americans to import lower cost medications for personal use. Well, Americans already do that and while its technically illegal, people aren’t prosecuted for doing so, and thus it’s generally permitted. But if it was expressly permitted it would remove the stigma of illegality, embolden many more consumers to import lower cost medication, deflate and defang the scare tactics of the pharmaceutical industry about importation and online pharmacies, and would instill more price competition into the U.S. market to bring down prices at local pharmacies.
A few questions. Don’t we need to pass a new law to “legalize” importation? Why do I choose to bold the phrase expressly permit? Would it be legal or expressly permitted? Maybe both? (more…)
Tagged with: bayh-dole, Congressional progressive caucus, march in rights, pay for delay
Yesterday, our CEO, Tod Cooperman, MD, applauded leading presidential candidates for supporting legal reforms to make it easier for Americans to buy lower cost medications from other countries.
“With millions of Americans doing this safely for more than a dozen years, it’s time for our government to stop threatening and scaring consumers and simply do what’s right: Make personal drug importation fully legal. Every presidential candidate should support this,” says Dr. Cooperman.
To read the full press release, go here: http://www.pharmacychecker.com/news/trump-clinton-sanders-support-drug-importation.asp.
Tagged with: Bernie Sanders, Donald Trump, Drug Importation, Hilary Clinton, Tod Cooperman
With its gift of $7.2 million to fund various research projects, the John and Laura Arnold Foundation gave a boost this week to the cause of lowering drug prices in America. According to the Foundation’s press release: “The research projects will focus on analyzing how regulatory policies and programs impact drug pricing, drug development, and patients’ access to medication.”
The lion’s share of the funds will go to the Memorial Sloane Kettering Cancer Center’s Evidence Driven Drug Pricing Project. Led by Dr. Peter Bach, the effort pursues strategies to evaluate the relative effectiveness of medications. The goal of Dr. Bach’s project is to make sure that medications are priced according to how well they actually work. Sounds like common sense, but too often medications that often don’t work are widely prescribed, and very expensive!
The money will also go toward various evidence-based studies looking into the workings of the drug development pipeline, state and federal regulations that affect Medicaid drug purchasing, and alternative Medicaid purchasing models that tie reimbursement to patient health outcomes.
One smaller project caught my eye, because it looks at pharmaceutical regulations and law that affect innovation. The Brigham and Woman’s Hospital’s Program on Regulations, Therapeutics, and Law will receive $748,445 to analyze existing regulations enacted to incentivize pharmaceutical innovation. The press release reads: “Researchers will analyze programs and incentives such as tax breaks, market exclusivity protections, and the Food and Drug Administration’s (FDA) fast-track approval pathways.”
In looking at regulations and law, the cause of lower drug prices would be well served by a research project dedicated to evaluating the effects of federal restrictions on prescription drug importation. Ostensibly, drug importation restrictions are in place to prevent unsafe and counterfeit medications from reaching patients, but we know that they also curtail access to lower cost, safe and effective medication as well. That’s why millions of Americans buy foreign medication online despite the prohibiting regulations.
New research would help determine a more suitable regulatory framework to protect patient health, but also expand access to more affordable medication through safe personal drug importation. This recent grant by the John and Laura Arnold Foundation is its second in the area of prescription drug prices. Three’s a charm!
Tagged with: Brigham and Woman’s Hospital, Drug Importation, Evidence Driven Drug Pricing Project, John and Laura Arnold Foundation, Memorial Sloane Kettering Cancer Center